Autologous B7-H3 CAR T cells
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Autologous B7-H3 CAR T cells, covering 2025-04-24 to 2026-04-24. Get the full timeline:
Most recent: Clinical Trial Update: Autologous B7-H3 Chimeric Antigen Receptor T Cells in Previously Treated Extensive-Stage Small Cell Lung Cancer With Recurrent or Refractory Disease [Phase 1]